NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/02/2025
Back to search
Official data from USPTO
WUXIAADDCC PLUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
12/03/2025
Trademark type
Combined
Nice classes
1, 5, 40, 42
Filing date
01/22/2024
Registration date
12/02/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/02/2025
Last transaction
12/03/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/25/2024
First use in commerce
01/25/2024
Drawing code
5
Owner type
99
Owner location
DUNDALK, CO LOUTH, IE
Examiner
PATEL,SAMIR RAMESH
Law office
L60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized words WuXiaADDCC PLUS with "ADDCC" in superscript to the right of the "a" in "WuXia".
Holders and representatives
Holders
WUXI BIOLOGICS IRELAND LIMITED
Representatives
Michael T. Smith Birch Stewart Kolasch & Birch, LLP
Technical classification
Nice Classes
Class 1Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological preparationsother than for medical or veterinary usegenetically modified cells and vectors for production of humananimal and synthetic proteinsfor clinical and commercial purposes in scientific research and for use in pharmaceutical research
Class 5
Biological preparations for medical usegenetically modified cells and genetically modified vectors for production of humananimal and synthetic proteins for medicalclinical and commercial use in human and animal therapies
Class 40
Custom manufacturing according to third-party orders and specifications of genetically modified cells and vectors for production of humananimal and synthetic proteinsfor clinical and commercial use in scientific research and in pharmaceutical researchas well as for clinical and commercial use in human and animal therapies
Class 42
Scientific and medical research in the field of biotechnology; Technical consultancy and project planning in the field of biological research relating to proteins; research and development in the field of protein research for others
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/02/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/08/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/08/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/07/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/07/2025
IUAF
USE AMENDMENT FILED
05/27/2025
EISU
TEAS STATEMENT OF USE RECEIVED
05/27/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/20/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/20/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/20/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
11/26/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2024
PUBO
PUBLISHED FOR OPPOSITION
10/15/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/11/2024
DOCK
ASSIGNED TO EXAMINER
07/11/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/18/2024
NWAP
NEW APPLICATION ENTERED
01/22/2024
Continuous trademark protection
Get notified about every new filing that threatens WUXIAADDCC PLUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.